News from APEIRON Biologics AG A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 27, 2017, 08:45 ET APEIRON Biologics Receives Green Light for Marketing Approval of a Neuroblastoma Immunotherapy in the European Union

APEIRON Biologics AG ("Apeiron") today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...


Dec 19, 2011, 09:00 ET Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone

APEIRON Biologics AG (Apeiron) announced today that GlaxoSmithKline (GSK), exclusive, worldwide licensee for Apeiron's new investigational...


Sep 29, 2011, 09:00 ET Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301)

Children's Oncology Group (COG) and APEIRON Biologics AG (Apeiron) announced today that they will jointly investigate Apeiron's APN301 in a...


Jun 22, 2011, 11:00 ET Oncology Alliance: Apeiron, CCRI and SIOPEN Join Forces Against Neuroblastoma

  Vienna based biotech company APEIRON Biologics AG (Apeiron) strengthens its oncology pipeline: The company will support the clinical...


Mar 15, 2011, 11:00 ET APEIRON Acquires Option to License Rights to Novel Oncology Compounds From Cleveland Clinic

Apeiron Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds....